Olshan Frome Wolosky LLP advised Anebulo Pharmaceuticals on the deal.Anebulo Pharmaceuticals, Inc. executed its $21 million initial public offering and listing on The Nasdaq Capital Market under…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
